Consequences of direct and indirect activation of dendritic cells on antigen presentation: Functional implications and clinical considerations

Molecular Immunology

Volumn 55, Issue 2, 2013, Pages 175-178

  Vega Ramos, Javier ^a   Villadangos, José A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antigen Presentation; Dendritic cell; Pathogen

Indexed keywords

HLA ANTIGEN CLASS 2; INTERFERON; TOLL LIKE RECEPTOR AGONIST;

ANTIGEN PRESENTATION; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; REVIEW;

ANTIGEN PRESENTATION; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84875619751     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.10.034     Document Type: Review

References (12)

1. Bouvier I., Jusforgues-Saklani H., Lim A., Lemaitre F., Lemercier B., Auriau C., Nicola M.A., Leroy S., Law H.K., Bandeira A., Moon J.J., Bousso P., Albert M.L. Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery. Frontiers in immunology 2011, 2:71.
2. Drutman S.B., Trombetta E.S. Dendritic cells continue to capture and present antigens after maturation in vivo. Journal of Immunology 2010, 185:2140-2146.
3. Joffre O., Nolte M.A., Sporri R., Reis e Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunological Reviews 2009, 227:234-247.
4. Lundie R.J., Young L.J., Davey G.M., Villadangos J.A., Carbone F.R., Heath W.R., Crabb B.S. Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells. European journal of immunology 2010, 40:1674-1681.
5. Njie R., Bell A.I., Jia H., Croom-Carter D., Chaganti S., Hislop A.D., Whittle H., Rickinson A.B. The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. Journal of Infectious Diseases 2009, 199:31-38.
6. Paul P., van den Hoorn T., Jongsma M.L., Bakker M.J., Hengeveld R., Janssen L., Cresswell P., Egan D.A., van Ham M., Ten Brinke A., Ovaa H., Beijersbergen R.L., Kuijl C., Neefjes J. A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell 2011, 145:268-283.
7. Platt C.D., Ma J.K., Chalouni C., Ebersold M., Bou-Reslan H., Carano R.A., Mellman I., Delamarre L. Mature dendritic cells use endocytic receptors to capture and present antigens. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:4287-4292.
8. Simmons D.P., Wearsch P.A., Canaday D.H., Meyerson H.J., Liu Y.C., Wang Y., Boom W.H., Harding C.V. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. Journal of immunology 2012, 188:3116-3126.
9. ten Broeke T., van Niel G., Wauben M.H., Wubbolts R., Stoorvogel W. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions. Traffic 2011, 12:1025-1036.
10. Villadangos J.A., Schnorrer P., Wilson N.S. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunological Reviews 2005, 207:191-205.
11. Wilson N.S., Behrens G.M., Lundie R.J., Smith C.M., Waithman J., Young L., Forehan S.P., Mount A., Steptoe R.J., Shortman K.D., de Koning-Ward T.F., Belz G.T., Carbone F.R., Crabb B.S., Heath W.R., Villadangos J.A. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nature Immunology 2006, 7:165-172.
12. Young L.J., Wilson N.S., Schnorrer P., Mount A., Lundie R.J., La Gruta N.L., Crabb B.S., Belz G.T., Heath W.R., Villadangos J.A. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:17753-17758.